Manus Rogan

Funding will drive commercialisation of Reactiv8 in critical US market

Group eyeing up to 10 investments, mostly in therapeutics and medical device sectors

Fundraising to push commercialisation and advance entry to US market oversubscirbed

Key players in Dublin-based start-up were involved in successful Inflazome venture

Company developing medicines for chronic inflammatory diseases such as Alzheimer’s

Group beats €100m target and intends to invest the bulk of the fund in Europe and US

Inflazome in one of the largest European biotech fundraisings this year as it targets range of serious inflammatory diseases

Inflazome has drug ready to enter human clinical trials

A trial of 47 patients showed after three months, 63 per cent reported clinically important improvement in back pain

Elan offshoot has now secured €103m for venture capital fund

Group targeting European investments in specialty pharma, biotech, medical devices and diagnostics

Proceeds will fund clinical trials of back pain device as shares float at lower end of guided range